BioFrontiers Chief Scientific Officer Leslie Leinwand, has been studying the motor protein, myosin, for 25 years. This important protein is responsible for making muscles contract, including one vital muscle: your heart. Leinwand recently won a $45,837 grant from the Children’s Cardiomyopathy Foundation (CCF) to study the differences in the myosin mutations in adult and pediatric populations. She also plans to look at the effects of a small molecule drug on the pediatric versions of the protein in a test tube. This small molecule drug has promise for treating adults with heart failure.